A molecular genetic and statistical approach for the diagnosis of dual-site cancers

Journal of the National Cancer Institute

Volumn 96, Issue 19, 2004, Pages 1441-1446

  Brinkmann, Dirk ^a   Ryan, Andy ^b   Ayhan, Ayse ^c   McCluggage, W Glen ^d   Feakins, Roger ^a   Santibanez Koref, Mauro F ^e   Mein, Charles A ^a   Gayther, Simon A ^b   Jacobs, Ian J ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c HACETTEPE UNIVERSITY   (Turkey)

^d ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

^e MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MICROSATELLITE DNA; TUMOR MARKER;

ALGORITHM; ARTICLE; CANCER CLASSIFICATION; CANCER GENETICS; CANCER LOCALIZATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DNA EXTRACTION; DNA FINGERPRINTING; DNA SEQUENCE; ENDOMETRIUM CANCER; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC SCREENING; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; MOLECULAR CLONING; MOLECULAR GENETICS; MULTIPLE CANCER; OVARY CANCER; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; CARCINOMA; CELL CLONE; CHROMOSOMAL INSTABILITY; ENDOMETRIUM TUMOR; GENE DELETION; GENETIC MARKER; GENETICS; MOLECULAR BIOLOGY; OVARY TUMOR; PATHOLOGY; PROGNOSIS; SECOND CANCER; STATISTICAL MODEL;

CARCINOMA; CHROMOSOMAL INSTABILITY; CLONE CELLS; DNA FINGERPRINTING; DNA, NEOPLASM; ENDOMETRIAL NEOPLASMS; FEMALE; GENE DELETION; GENETIC MARKERS; HUMANS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; MODELS, STATISTICAL; MOLECULAR BIOLOGY; NEOPLASMS, MULTIPLE PRIMARY; NEOPLASMS, SECOND PRIMARY; OVARIAN NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 6944251324     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/djh272     Document Type: Article

References (47)

1. Matlock DL, Salem FA, Charles EH, Savage EW. Synchronous multiple primary neoplasms of the upper female genital tract. Gynecol Oncol 1982;13:271-7.
2. Zaino RJ, Unger ER, Whitney C. Synchronous carcinomas of the uterine corpus and ovary. Gynecol Oncol 1984;19:329-35.
3. Eisner RF, Nieberg RK, Berek JS. Synchronous primary neoplasms of the female reproductive tract. Gynecol Oncol 1989;33:335-9.
4. Piura B, Glezerman M. Synchronous carcinomas of endometrium and ovary. Gynecol Oncol 1989;33:261-4.
5. Ayhan A, Yalcin OT, Tuncer ZS, Gurgan T, Kucukali T. Synchronous primary malignancies of the female genital tract. Eur J Obstet Gynecol Reprod Biol 1992;45:63-6.
6. Koness RJ, King TC, Schechter S, McLean SF, Lodowsky C, Wanebo HJ. Synchronous colon carcinomas: molecular-genetic evidence for multicentricity. Ann Surg Oncol 1996;3:136-43.
7. Huang J, Behrens C, Wistuba I, Gazdar AF, Jagirdar J. Molecular analysis of synchronous and metachronous tumors of the lung: Impact on management and prognosis. Ann Diagn Pathol 2001;5:321-9.
8. Ulbright TM, Roth LM. Metastatic and independent cancers of the endometrium and ovary: a clinicopathologic study of 34 cases. Hum Pathol 1985;16:28-34.
9. Scully RE, Richardson GS, Barlow JF. The development of malignancy in endometriosis. Clin Obstet Gynecol 1966;9:384-411.
10. Young RH, Scully RE. Metastatic tumors in the ovary: a problem-oriented approach and review of the recent literature. Semin Diagn Pathol 1991;8: 250-76.
11. Scully RE, Young RH, Clement PB. Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament: atlas of tumor pathology. Silver Spring (MD): American Registry of Pathology; 1999.
12. Castro IM, Connell PP, Waggoner S, Rotmensch J, Mundt AJ. Synchronous ovarian and endometrial malignancies. Am J Clin Oncol 2000;23: 521-5.
13. Fujikawa K, Sasaki M, Aoyama T, Itoh T, Yoshida O. Intratumoral heterogeneity in prostate cancer demonstrated by volume-weighted mean nuclear volume. Apmis 1997;105:322-8.
14. Sharifi-Salamatian V, de Roquancourt A, Rigaut JP. Breast carcinoma, intratumour heterogeneity and histological grading, using geostatistics. Anal Cell Pathol 2000;20:83-91.
15. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet 1992;51:1229-39.
16. Cheng PC, Gosewehr JA, Kim TM, Velicescu M, Wan M, Zheng J, et al. Potential role of the inactivated X chromosome in ovarian epithelial tumor development [see comments]. J Natl Cancer Inst 1996;88:510-8.
17. Mashal RD, Fejzo ML, Friedman AJ, Mitchner N, Nowak RA, Rein MS, et al. Analysis of androgen receptor DNA reveals the independent clonal origins of uterine leiomyomata and the secondary nature of cytogenetic aberrations in the development of leiomyomata. Genes Chromosomes Cancer 1994;11:1-6.
18. Sidransky D, Frost P, Von Eschenbach A, Oyasu R, Preisinger AC, Vogelstein B. Clonal origin bladder cancer. N Engl J Med 1992;326:737-40.
19. Dinjens WN, van der Burg ME, Chadha S, Sleddens HF, Burger CW, Ewing PC. Clinical importance of molecular determinations in gynecologic patients with multiple tumors. Cancer 2003;97:1766-74.
20. Wenz HM, Dailey D, Johnson MD. Development of a high-throughput capillary electrophoresis protocol for DNA fragment analysis. Methods Mol Biol 2001;163:3-17.
21. Fujita M, Enomoto T, Wada H, Inoue M, Okudaira Y, Shroyer KR. Application of clonal analysis. Differential diagnosis for synchronous primary ovarian and endometrial cancers and metastatic cancer. Am J Clin Pathol 1996;105:350-9.
22. Pearl ML, Johnston CM, Frank TS, Roberts JA. Synchronous dual primary ovarian and endometrial carcinomas. Int J Gynaecol Obstet 1993;43:305-12.
23. Sheu BC, Lin HH, Chen CK, Chao KH, Shun CT, Huang SC. Synchronous primary carcinomas of the endometrium and ovary. Int J Gynaecol Obstet 1995;51:141-6.
24. Russell P, Bannatyne PM, Solomon HJ, Stoddard LD, Tattersall MH. Multifocal tumorigenesis in the upper female genital tract - implications for staging and management. Int J Gynecol Pathol 1985;4:192-210.
25. Annegers JF, Malkasian GD, Jr. Patterns of other neoplasia in patients with endometrial carcinoma. Cancer 1981;48:856-9.
26. Czernobilsky B, Silverman BB, Mikuta JJ. Endometrioid carcinoma of the ovary. A clinicopathologic study of 75 cases. Cancer 1970;26:1141-52.
27. Eifel P, Hendrickson M, Ross J, Ballon S, Martinez A, Kempson R. Simultaneous presentation of carcinoma involving the ovary and the uterine corpus. Cancer 1982;50:163-70.
28. Young RC. The treatment of early stage ovarian cancer. Semin Oncol 1995;22:76-9.
29. Abeln EC, Kuipers-Dijkshoorn NJ, Berns EM, Henzen-Logmans SC, Fleuren GJ, Cornelisse CJ. Molecular genetic evidence for unifocal origin of advanced epithelial ovarian cancer and for minor clonal divergence. Br J Cancer 1995;72:1330-6.
30. Pejovic T, Heim S, Mandahl N, Elmfors B, Furgyik S, Floderus UM, et al. Bilateral ovarian carcinoma: cytogenetic evidence of unicentric origin. Int J Cancer 1991;47:358-61.
31. Diaz-Cano SJ, Brady SP. DNA extraction from formalin-fixed, paraffin-embedded tissues: protein digestion as a limiting step for retrieval of high-quality DNA. Diagn Mol Pathol 1997;6:342-6.
32. Cliby W, Ritland S, Hartmann L, Dodson M, Halling KC, Keeney G, et al. Human epithelial ovarian cancer allelotype. Cancer Res 1993;53:2393-8.
33. Fujino T, Risinger JI, Collins NK, Liu FS, Nishii H, Takahashi H, et al. Allelotype of endometrial carcinoma. Cancer Res 1994;54:4294-8.
34. Gabra H, Langdon SP, Watson JE, Hawkins RA, Cohen BB, Taylor L, et al. Loss of heterozygosity at 11q22 correlates with low progesterone receptor content in epithelial ovarian cancer. Clin Cancer Res 1995;1:945-53.
35. Imamura T, Arima T, Kato H, Miyamoto S, Sasazuki T, Wake N. Chromosomal deletions and K-ras gene mutations in human endometrial carcinomas. Int J Cancer 1992;51:47-52.
36. Jones MH, Koi S, Fujimoto I, Hasumi K, Kato K, Nakamura Y. Allelotype of uterine cancer by analysis of RFLP and microsatellite polymorphisms: frequent loss of heterozygosity on chromosome arms 3p, 9q, 10q, and 17p. Genes Chromosomes Cancer 1994;9:119-23.
37. Kiechle-Schwarz M, Bauknecht T, Wienker T, Walz L, Pfleiderer A. Loss of constitutional heterozygosity on chromosome 11p in human ovarian cancer. Positive correlation with grade of differentiation. Cancer 1993;72: 2423-32.
38. Okamoto A, Sameshima Y, Yamada Y, Teshima S, Terashima Y, Terada M, et al. Allelic loss on chromosome 17p and p53 mutations in human endometrial carcinoma of the uterus. Cancer Res 1991;51:5632-5.
39. Osborne RJ, Leech V. Polymerase chain reaction allelotyping of human ovarian cancer. Br J Cancer 1994;69:429-38.
40. Peiffer SL, Herzog TJ, Tribune DJ, Mutch DG, Gersell DJ, Goodfellow PJ. Allelic loss of sequences from the long arm of chromosome 10 and replication errors in endometrial cancers. Cancer Res 1995;55:1922-6.
41. Pieretti M, Powell DE, Gallion HH, Case EA, Conway PS, Turker MS. Genetic alterations on chromosome 17 distinguish different types of epithelial ovarian tumors. Hum Pathol 1995;26:393-7.
42. Sasatomi E, Finkelstein SD, Woods JD, Bakker A, Swalsky PA, Luketich JD, et al. Comparison of accumulated allele loss between primary tumor and lymph node metastasis in stage II non-small cell lung carcinoma: implications for the timing of lymph node metastasis and prognostic value. Cancer Res 2002;62:2681-9.
43. Shenson DL, Gallion HH, Powell DE, Pieretti M. Loss of heterozygosity and genomic instability in synchronous endometrioid tumors of the ovary and endometrium. Cancer 1995;76:650-7.
44. Einbeigi Z, Meis-Kindblom JM, Kindblom LG, Wallgren A, Karlsson P. Clustering of individuals with both breast and ovarian cancer - a possible indicator of BRCA founder mutations. Acta Oncol 2002;41:153-7.
45. Curtin JP, Barakat RR, Hoskins WJ. Ovarian disease in women with breast cancer. Obstet Gynecol 1994;84:449-52.
46. van Oijen MG, Leppers Vd Straat FG, Tilanus MG, Slootweg PJ. The origins of multiple squamous cell carcinomas in the aerodigestive tract. Cancer 2000;88:884-93.
47. Louhelainen J, Wijkstrom H, Hemminki K. Allelic losses demonstrate monoclonality of multifocal bladder tumors. Int J Cancer 2000;87:522-7.